LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 208

Search options

  1. Book ; Online: Co-curating the City

    Melhuish, Clare / Benesch, Henri / Sully, Dean / Holmberg, Ingrid Martins

    Universities and urban heritage past and future

    2022  

    Keywords City & town planning - architectural aspects ; History of architecture ; Museology & heritage studies ; Urban communities ; Higher & further education, tertiary education ; Urban & municipal planning ; urban studies ; planning ; architecture ; universities ; higher education ; heritage ; urban development ; regeneration ; built environment ; UCL ; UCLEast
    Language 0|e
    Size 1 Online-Ressource
    Publisher UCL Press
    Publishing place London
    Document type Book ; Online
    Note English ; Open Access
    HBZ-ID HT021613346
    ISBN 9781800081864 ; 1800081863
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    More links

    Kategorien

  2. Article ; Online: Hepatoblastoma in molecularly defined, congenital diseases.

    Nussbaumer, Gunther / Benesch, Martin

    American journal of medical genetics. Part A

    2022  Volume 188, Issue 9, Page(s) 2527–2535

    Abstract: Beckwith-Wiedemann spectrum, Simpson-Golabi-Behmel syndrome, familial adenomatous polyposis and trisomy 18 are the most common congenital conditions associated with an increased incidence of hepatoblastoma (HB). In patients with these genetic disorders, ... ...

    Abstract Beckwith-Wiedemann spectrum, Simpson-Golabi-Behmel syndrome, familial adenomatous polyposis and trisomy 18 are the most common congenital conditions associated with an increased incidence of hepatoblastoma (HB). In patients with these genetic disorders, screening protocols for HB are proposed that include periodic abdominal ultrasound and measurement of alpha-fetoprotein levels. Surveillance in these children may contribute to the early detection of HB and possibly improve their chances of overall survival. Therefore, physicians must be aware of the high HB incidence in children with certain predisposing genetic diseases.
    MeSH term(s) Beckwith-Wiedemann Syndrome/diagnosis ; Beckwith-Wiedemann Syndrome/epidemiology ; Beckwith-Wiedemann Syndrome/genetics ; Child ; Genetic Diseases, X-Linked/genetics ; Gigantism/genetics ; Hepatoblastoma/diagnosis ; Hepatoblastoma/epidemiology ; Hepatoblastoma/genetics ; Humans ; Liver Neoplasms/complications ; Liver Neoplasms/diagnosis ; Liver Neoplasms/genetics
    Language English
    Publishing date 2022-04-28
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2108614-X
    ISSN 1552-4833 ; 0148-7299 ; 1552-4825
    ISSN (online) 1552-4833
    ISSN 0148-7299 ; 1552-4825
    DOI 10.1002/ajmg.a.62767
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent MRI lesions after first-line treatment.

    Obrecht-Sturm, Denise / Schömig, Lena / Mynarek, Martin / Bison, Brigitte / Schwarz, Rudolf / Pietsch, Torsten / Pfister, Stefan M / Sill, Martin / Sturm, Dominik / Sahm, Felix / Kortmann, Rolf-Dieter / Gerber, Nicolas U / von Bueren, André O / Fleischhack, Gudrun / Schüller, Ulrich / Nussbaumer, Gunther / Benesch, Martin / Rutkowski, Stefan

    Neuro-oncology

    2024  

    Abstract: Background: This study aims at clarifying the impact of persistent residual lesions following first-line treatment for pediatric medulloblastoma.: Methods: Data on 84 pediatric patients with medulloblastoma and persistent residual lesions on ... ...

    Abstract Background: This study aims at clarifying the impact of persistent residual lesions following first-line treatment for pediatric medulloblastoma.
    Methods: Data on 84 pediatric patients with medulloblastoma and persistent residual lesions on centrally reviewed MRI at the end of first-line therapy were analyzed.
    Results: Twenty patients (23.8%) had residual lesions in the tumor bed (R+/M0), 51 (60.7%) had distant lesions (R0/M+) and 13 (15.5%) had both (R+/M+). Overall response to first-line therapy was minor or partial (≥25% reduction, MR/PR) for 64 (76.2%) and stable disease (SD) for 20 patients (23.8%). Five-year post-primary-treatment progression-free (pptPFS) and overall survival (pptOS) were superior after MR/PR (pptPFS: 62.5±7.0%[MR/PR] vs. 35.9±12.8%[SD], p=0.03; pptOS: 79.7±5.9[MR/PR] vs. 55.5±13.9[SD], p=0.04). Further, R+/M+ was associated with a higher risk for progression (5-year pptPFS: 22.9±17.9%[R+,M+] vs. 72.4±12.0%[R+,M0]; p=0.03). Watch-and-wait was pursued in 58 patients, while n=26 received additional treatments (chemotherapy only, n=19; surgery only, n=2; combined, n=3; valproic acid, n=2), and their outcomes were not superior to watch-and-wait (5-year pptPFS: 58.5±7.7% vs. 51.6±10.7% p=0.71; 5-year pptOS: 76.3±6.9% vs. 69.8±9.7%, p=0.74). For the whole cohort, five-year pptPFS by molecular subgroup (58 cases) were WNT: 100%, SHH: 50.0±35.4%, Group-4, 52.5±10.5, Group-3 54.2±13.8%; (p=0.08).
    Conclusion: Overall response and extent of lesions can function as surrogate parameters to predict outcomes in pediatric MB patients with persistent lesions after first-line therapy. Especially in case of solitary persistent medulloblastoma MRI lesion, additional therapy was not beneficial. Therefore, treatment response, extent/kind of residual lesions and further diagnostic information needs consideration for indication of additional treatments for persisting lesions.
    Language English
    Publishing date 2024-04-05
    Publishing country England
    Document type Journal Article
    ZDB-ID 2028601-6
    ISSN 1523-5866 ; 1522-8517
    ISSN (online) 1523-5866
    ISSN 1522-8517
    DOI 10.1093/neuonc/noae071
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study.

    Perwein, Thomas / Giese, Barbara / Nussbaumer, Gunther / von Bueren, André O / van Buiren, Miriam / Benesch, Martin / Kramm, Christof Maria

    Journal of neuro-oncology

    2023  Volume 161, Issue 3, Page(s) 525–538

    Abstract: Purpose: As there is no standard of care treatment for recurrent/progressing pediatric high-grade gliomas (pHGG), we aimed to gain an overview of different treatment strategies.: Methods: In a web-based questionnaire, members of the SIOPE-BTG and the ...

    Abstract Purpose: As there is no standard of care treatment for recurrent/progressing pediatric high-grade gliomas (pHGG), we aimed to gain an overview of different treatment strategies.
    Methods: In a web-based questionnaire, members of the SIOPE-BTG and the GPOH were surveyed on therapeutic options in four case scenarios (children/adolescents with recurrent/progressing HGG).
    Results: 139 clinicians with experience in pediatric neuro-oncology from 22 European countries participated in the survey. Most respondents preferred further oncological treatment in three out of four cases and chose palliative care in one case with marked symptoms. Depending on the case, 8-92% would initiate a re-resection (preferably hemispheric pHGG), combined with molecular diagnostics. Throughout all case scenarios, 55-77% recommended (re-)irradiation, preferably local radiotherapy > 20 Gy. Most respondents would participate in clinical trials and use targeted therapy (79-99%), depending on molecular genetic findings (BRAF alterations: BRAF/MEK inhibitor, 64-88%; EGFR overexpression: anti-EGFR treatment, 46%; CDKN2A deletion: CDK inhibitor, 18%; SMARCB1 deletion: EZH2 inhibitor, 12%). 31-72% would administer chemotherapy (CCNU, 17%; PCV, 8%; temozolomide, 19%; oral etoposide/trofosfamide, 8%), and 20-69% proposed immunotherapy (checkpoint inhibitors, 30%; tumor vaccines, 16%). Depending on the individual case, respondents would also include bevacizumab (6-18%), HDAC inhibitors (4-15%), tumor-treating fields (1-26%), and intraventricular chemotherapy (4-24%).
    Conclusion: In each case, experts would combine conventional multimodal treatment concepts, including re-irradiation, with targeted therapy based on molecular genetic findings. International cooperative trials combining a (chemo-)therapy backbone with targeted therapy approaches for defined subgroups may help to gain valid clinical data and improve treatment in pediatric patients with recurrent/progressing HGG.
    MeSH term(s) Adolescent ; Humans ; Child ; Brain Neoplasms/therapy ; Brain Neoplasms/drug therapy ; Proto-Oncogene Proteins B-raf ; Glioma/therapy ; Glioma/drug therapy ; Temozolomide/therapeutic use ; Bevacizumab/therapeutic use ; Chronic Disease
    Chemical Substances Proto-Oncogene Proteins B-raf (EC 2.7.11.1) ; Temozolomide (YF1K15M17Y) ; Bevacizumab (2S9ZZM9Q9V)
    Language English
    Publishing date 2023-02-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 604875-4
    ISSN 1573-7373 ; 0167-594X
    ISSN (online) 1573-7373
    ISSN 0167-594X
    DOI 10.1007/s11060-023-04241-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Bilateral testicular juvenile granulosa cell tumor: Tumor control with conservative, antihormonal therapy.

    Nussbaumer, Gunther / Benesch, Martin / Bokros, Agnes / Brecht, Ines B / Speicher, Irene / Suppan, Elisabeth / Tschauner, Sebastian / Vokuhl, Christian / Schneider, Dominik T

    Pediatric blood & cancer

    2022  , Page(s) e29895

    Language English
    Publishing date 2022-08-04
    Publishing country United States
    Document type Letter
    ZDB-ID 2131448-2
    ISSN 1545-5017 ; 1545-5009
    ISSN (online) 1545-5017
    ISSN 1545-5009
    DOI 10.1002/pbc.29895
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Correction to: The Immune Deficiency and Dysregulation Activity (IDDA2.1 'Kaleidoscope') Score and Other Clinical Measures in Inborn Errors of Immunity.

    Seidel, Markus G / Tesch, Victoria K / Yang, Linlin / Hauck, Fabian / Horn, Anna Lena / Smolle, Maria Anna / Quehenberger, Franz / Benesch, Martin

    Journal of clinical immunology

    2022  Volume 42, Issue 3, Page(s) 499

    Language English
    Publishing date 2022-02-09
    Publishing country Netherlands
    Document type Published Erratum
    ZDB-ID 779361-3
    ISSN 1573-2592 ; 0271-9142
    ISSN (online) 1573-2592
    ISSN 0271-9142
    DOI 10.1007/s10875-022-01220-w
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: How far should we go with cost-utility analysis when treating children with acute idiopathic thrombocytopenic purpura?

    Benesch, Martin

    Pediatric blood & cancer

    2008  Volume 50, Issue 2, Page(s) 433

    MeSH term(s) Child ; Cost-Benefit Analysis ; Decision Support Techniques ; Drug Costs ; Drug Therapy/economics ; Humans ; Immunoglobulins, Intravenous/economics ; Immunoglobulins, Intravenous/therapeutic use ; Methylprednisolone/economics ; Methylprednisolone/therapeutic use ; Purpura, Thrombocytopenic, Idiopathic/drug therapy ; Purpura, Thrombocytopenic, Idiopathic/economics
    Chemical Substances Immunoglobulins, Intravenous ; Methylprednisolone (X4W7ZR7023)
    Language English
    Publishing date 2008-02
    Publishing country United States
    Document type Comment ; Letter
    ZDB-ID 2131448-2
    ISSN 1545-5017 ; 1545-5009
    ISSN (online) 1545-5017
    ISSN 1545-5009
    DOI 10.1002/pbc.21231
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Concurrence of a kinase-dead BRAF and an oncogenic KRAS gain-of-function mutation in juvenile xanthogranuloma.

    Seidel, Markus G / Brcic, Luka / Hoefler, Gerald / Hutter, Caroline / Minkov, Milen / Steffen, Laura Sophie / Zebisch, Armin / Benesch, Martin

    Pediatric blood & cancer

    2022  Volume 70, Issue 4, Page(s) e30060

    MeSH term(s) Humans ; Proto-Oncogene Proteins B-raf/genetics ; Gain of Function Mutation ; Proto-Oncogene Proteins p21(ras)/genetics ; Xanthogranuloma, Juvenile/genetics ; Colorectal Neoplasms/genetics ; Mutation
    Chemical Substances Proto-Oncogene Proteins B-raf (EC 2.7.11.1) ; Proto-Oncogene Proteins p21(ras) (EC 3.6.5.2) ; KRAS protein, human ; BRAF protein, human (EC 2.7.11.1)
    Language English
    Publishing date 2022-11-01
    Publishing country United States
    Document type Editorial ; Research Support, Non-U.S. Gov't
    ZDB-ID 2131448-2
    ISSN 1545-5017 ; 1545-5009
    ISSN (online) 1545-5017
    ISSN 1545-5009
    DOI 10.1002/pbc.30060
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Prognostic Impact of Pulmonary Metastasectomy in Bone Sarcoma Patients: A Retrospective, Single-Centre Study.

    Smolle, Maria Anna / Kogler, Angelika / Andreou, Dimosthenis / Scheipl, Susanne / Bergovec, Marko / Castellani, Christoph / Till, Holger / Benesch, Martin / Posch, Florian / Szkandera, Joanna / Smolle-Jüttner, Freyja-Maria / Leithner, Andreas

    Cancers

    2023  Volume 15, Issue 6

    Abstract: This retrospective study aimed at analyzing the impact of metastasectomy on post-metastasis survival (PMS) in bone sarcoma patients with lung metastases. Altogether, 47 bone sarcoma patients (24 males, median age at diagnosis of lung metastases: 21.8 ( ... ...

    Abstract This retrospective study aimed at analyzing the impact of metastasectomy on post-metastasis survival (PMS) in bone sarcoma patients with lung metastases. Altogether, 47 bone sarcoma patients (24 males, median age at diagnosis of lung metastases: 21.8 (IQR: 15.6-47.3) years) with primary (n = 8) or secondary (n = 39) lung metastases treated at a single university hospital were retrospectively included. Based on a propensity score, inverse probability of treatment weight (IPTW) was calculated to account for selection bias whether patients had undergone metastasectomy or not. The most common underlying histology was osteosarcoma (n = 37; 78.7%). Metastasectomy was performed in 39 patients (83.0%). Younger patients (
    Language English
    Publishing date 2023-03-13
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers15061733
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Rapidly involuting congenital hemangioma of the liver in a newborn with incomplete Pentalogy of Cantrell: description of a new association.

    Gasparella, Paolo / Singer, Georg / Arneitz, Christoph / Benesch, Martin / Sorantin, Erich / Kampelmühler, Eva / Schemmer, Peter / Till, Holger

    Journal of surgical case reports

    2021  Volume 2021, Issue 3, Page(s) rjab047

    Abstract: The perinatal management of newborns with giant omphaloceles requires careful suspicion concerning 'unexpected' associated malformations. We describe a newborn with a combination of incomplete Pentalogy of Cantrell consisting of giant omphalocele, ... ...

    Abstract The perinatal management of newborns with giant omphaloceles requires careful suspicion concerning 'unexpected' associated malformations. We describe a newborn with a combination of incomplete Pentalogy of Cantrell consisting of giant omphalocele, anterior congenital diaphragmatic hernia (CDH) and pericardial absence complicated by a hepatic rapidly involuting congenital hemangioma (RICH). A giant omphalocele was detected prenatally. Postnatally, staged closure of the omphalocele was planned. A mass of the liver was noted and (mis-)taken for a hematoma. In the further course, the baby developed cardiorespiratory insufficiency due to a central CDH which was excised. Subsequently, staged closure of the omphalocele became impossible. Specific workup revealed a mass in the left liver lobe. The mass was resected and the abdominal wall defect repaired. Histology confirmed the diagnosis of an RICH. The surgical treatment of newborns with giant omphaloceles requires a multidisciplinary neonatal support and an elaborate pediatric surgical armamentarium to cope with additional malformations.
    Language English
    Publishing date 2021-03-22
    Publishing country England
    Document type Case Reports
    ISSN 2042-8812
    ISSN 2042-8812
    DOI 10.1093/jscr/rjab047
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top